For the purposes of this Regulation, the definitions of the Convention and the Nagoya Protocol as well as the following definitions apply:

1. (1)

   ‘genetic material’ means any material of plant, animal, microbial or other origin containing functional units of heredity;

2. (2)

   ‘genetic resources’ means genetic material of actual or potential value;

3. (3)

   ‘access’ means the acquisition of genetic resources or of traditional knowledge associated with genetic resources in a Party to the Nagoya Protocol;

4. (4)

   ‘user’ means a natural or legal person that utilises genetic resources or traditional knowledge associated with genetic resources;

5. (5)

   ‘utilisation of genetic resources’ means to conduct research and development on the genetic and/or biochemical composition of genetic resources, including through the application of biotechnology as defined in Article 2 of the Convention;

6. (6)

   ‘mutually agreed terms’ means the contractual arrangements concluded between a provider of genetic resources, or of traditional knowledge associated with genetic resources, and a user, that set out specific conditions for the fair and equitable sharing of benefits arising from the utilisation of genetic resources or of traditional knowledge associated with genetic resources, and that may also include further conditions and terms for such utilisation as well as subsequent applications and commercialisation;

7. (7)

   ‘traditional knowledge associated with genetic resources’ means traditional knowledge held by an indigenous or local community that is relevant for the utilisation of genetic resources and that is as such described in the mutually agreed terms applying to the utilisation of genetic resources;

8. (8)

   ‘illegally accessed genetic resources’ means genetic resources and traditional knowledge associated with genetic resources which were not accessed in accordance with the national access and benefit-sharing legislation or regulatory requirements of the provider country that is a Party to the Nagoya Protocol requiring prior informed consent;

9. (9)

   ‘collection’ means a set of collected samples of genetic resources and related information that is accumulated and stored, whether held by public or private entities;

10. (10)

    F1“associations of users” means an organisation that represents the interests of users in the United Kingdom and that is involved in developing and overseeing the best practices referred to in Article 8 of this Regulation;

11. (11)

    ‘internationally recognised certificate of compliance’ means a permit or its equivalent issued at the time of access as evidence that the genetic resource it covers has been accessed in accordance with the decision to grant prior informed consent, and that mutually agreed terms have been established for the user and the utilisation specified therein by a competent authority in accordance with Article 6(3)(e) and Article 13(2) of the Nagoya Protocol, that is made available to the Access and Benefit-sharing Clearing House established under Article 14(1) of that Protocol.

12. (12)

    F2“serious cross-border threat to health” means a life-threatening or otherwise serious hazard to health of biological, chemical, environmental or unknown origin which spreads or entails a significant risk of spreading across national borders, and which may necessitate international coordination in order to ensure a high level of human health protection.